Portal de Periódicos da CAPES

Geographic atrophy: clinical impact and emerging treatments

2015; Volume: 46; Issue: 1 Linguagem: Inglês

10.3928/23258160-20150101-01

2325-8179

Hershel R. Patel, David Eichenbaum,

Antioxidant Activity and Oxidative Stress

Practical RetinaGeographic atrophy: clinical impact and emerging treatments Hershel R. Patel, MS, MD, , , MS, MD David Eichenbaum, MD, , and , MD Seenu M. Hariprasad, Hershel R. Patel, MS, MD , David Eichenbaum, MD , and Published OnlineJanuary 01, 2015https://doi.org/10.3928/23258160-20150101-01Cited by:12PDFView Full Text ToolsAdd to favoritesDownload CitationsTrack Citations ShareShare onFacebookTwitterLinkedInRedditEmail SectionsMore1.Lim LS, Mitchell P, Seddon JM, Holz FG, Wong TY. Age-related macular degeneration. Lancet. 2012; 379(9827):1728–1738.10.1016/S0140-6736(12)60282-7 Crossref MedlineGoogle Scholar2.Bhutto I, Lutty G. Understanding age-related macular degeneration (AMD): relationships between the photoreceptor/retinal pigment epithelium/Bruch's membrane/choriocapillaris complex. Mol Aspects Med. 2012; 33(4):295–317.10.1016/j.mam.2012.04.005 Crossref MedlineGoogle Scholar3.Sunness JS. The natural history of geographic atrophy, the advanced atrophic form of age-related macular degeneration. Mol Vis. 1999; 5:25. MedlineGoogle Scholar4.Holz FG, Strauss EC, Schmitz-Valckenberg S, van Lookeren Campagne M. Geographic atrophy: clinical features and potential therapeutic approaches. Ophthalmology. 2014; 121(5):1079–1091.10.1016/j.ophtha.2013.11.023 Crossref MedlineGoogle Scholar5.Tomany SC, Wang JJ, Van Leeuwen R, et al.Risk factors for incident age-related macular degeneration: pooled findings from 3 continents. Ophthalmology. 2004; 111(7):1280–1287.10.1016/j.ophtha.2003.11.010 Crossref MedlineGoogle Scholar6.Coleman HR, Chan CC, Ferris FL, Chew EY. Age-related macular degeneration. Lancet. 2008; 372(9652):1835–1845.10.1016/S0140-6736(08)61759-6 Crossref MedlineGoogle Scholar7.Chew EY, Clemons TE, Agrón E, et al.Age-Related Eye Disease Study Research Group. Long-term effects of vitamins C and E, ß-carotene, and zinc on age-related macular degeneration: AREDS report no. 35. Ophthalmology. 2013; 120(8):1604–1611.10.1016/j.ophtha.2013.01.021 Crossref MedlineGoogle Scholar8.Damico FM, Gasparin F, Scolari MR, Pedral LS, Takahashi BS. New approaches and potential treatments for dry age-related macular degeneration. Arq Bras Oftalmol. 2012; 75(1):71–6. Crossref MedlineGoogle Scholar9.Tatton W, Chen D, Chalmers-Redman R, Wheeler L, Nixon R, Tatton N. Hypothesis for a common basis for neuroprotection in glaucoma and Alzheimer's disease: anti-apoptosis by alpha-2-adrenergic receptor activation. Surv Ophthalmol. 2003; 48Suppl 1:S25–3710.1016/S0039-6257(03)00005-5 Crossref MedlineGoogle Scholar10. ClinicalTrials.gov Identifier: NCT00658619. Safety and Efficacy of Brimonidine Intravitreal Implant in Patients With Geographic Atrophy Due to Age-related Macular Degeneration (AMD). http://clinicaltrials.gov/ct2/show/NCT00658619?term=NCT00658619&rank=1 Google Scholar11. ClinicalTrials.gov Identifier: NCT02087085. A Safety and Efficacy Study of Brimonidine Intravitreal Implant in Geographic Atrophy Secondary to Age-related Macular Degeneration (BEACON). http://clinicaltrials.gov/ct2/show/study/NCT02087085?term=brimonidine+geographic&rank=2 Google Scholar12.Tsao SW, Fong DS. Do statins have a role in the prevention of age-related macular degeneration?Drugs Aging. 2013; 30(4):205–213.10.1007/s40266-013-0061-4 Crossref MedlineGoogle Scholar13.Johnson LV, Leitner WP, Rivest AJ, Staples MK, Radeke MJ, Anderson DH. The Alzheimer's A beta -peptide is deposited at sites of complement activation in pathologic deposits associated with aging and age-related macular degeneration. Proc Natl Acad Sci U S A. 2002; 99(18):11830–11835.10.1073/pnas.192203399 Crossref MedlineGoogle Scholar14.Leyhe T, Andreasen N, Simeoni M, et al.Modulation of beta-amyloid by a single dose of GSK933776 in patients with mild Alzheimer's disease: a Phase I study. Alzheimers Res Ther. 2014; 6(2):19.10.1186/alzrt249 Crossref MedlineGoogle Scholar15.Schmitz-Valckenberg S, Alten F, Steinberg JS, et al.Geographic Atrophy Progression (GAP) Study Group. Reticular drusen associated with geographic atrophy in age-related macular degeneration. Invest Ophthalmol Vis Sci. 2011; 52(9):5009–5015.10.1167/iovs.11-7235 Crossref MedlineGoogle Scholar16.Chiou C. Is dry AMD treatable?Retina Today. May2012. http://bmctoday.net/retinatoday/2012/05/article.asp?f=is-dry-amd-treatable Google Scholar17.Mathis AE. Hope for dry AMD?Retinal Physician. http://www.reti-nalphysician.com/articleviewer.aspx?articleID=107893 Google Scholar18.Schmitz-Valckenberg S, Mössner A, Fleckenstein M, Wiedemann P, Holz FG. [Therapy approaches for geographic atrophy]. Ophthalmologe. 2010; 107(11):1016–1019.10.1007/s00347-010-2160-5 Crossref MedlineGoogle Scholar19.Mata NL, Lichter JB, Vogel R, Han Y, Bui TV, Singerman LJ. Investigation of oral fenretinide for treatment of geographic atrophy in age-related macular degeneration. Retina. 2013; 33(3):498–507.10.1097/IAE.0b013e318265801d Crossref MedlineGoogle Scholar20. http://www.amd.org/research/dry-amd-research/dry-amd-clinical-trials/52-fenretinide-pill.html Google Scholar21.Roche. Investor update. August 27, 2013. http://www.roche.com/investors/ir_update/inv-update-2013-08-27.htm Google Scholar22.Schwartz SD, Hubschman JP, Heilwell G, et al.Embryonic stem cell trials for macular degeneration: a preliminary report. Lancet. 2012; 379(9817):713–720.10.1016/S0140-6736(12)60028-2 Crossref MedlineGoogle Scholar23. ClinicalTrials.gov Identifier: NCT01344993. Safety and Tolerability of Sub-retinal Transplantation of hESC Derived RPE (MA09-hRPE) Cells in Patients With Advanced Dry Age Related Macular Degeneration (Dry AMD). http://clinicaltrials.gov/ct2/show/NCT01344993?term=MA09&rank=4 Google Scholar Next article FiguresReferencesRelatedDetailsCited by Ho J, Jang K, Koo T, Park C, Kim Y, Lee J and Kim E (2021) Protective effects of PARP1-inhibitory compound in dry age-related macular degeneration, Biomedicine & Pharmacotherapy, 10.1016/j.biopha.2020.111041, 133, (111041), Online publication date: 1-Jan-2021. Melinscak M, Radmilovic M, Vatavuk Z and Loncaric S (2021) AROI: Annotated Retinal OCT Images Database 2021 44th International Convention on Information, Communication and Electronic Technology (MIPRO), 10.23919/MIPRO52101.2021.9596934, 978-953-233-101-1, (371-376) Melinščak M, Radmilović M, Vatavuk Z and Lončarić S (2021) Annotated retinal optical coherence tomography images (AROI) database for joint retinal layer and fluid segmentation, Automatika, 10.1080/00051144.2021.1973298, 62:3-4, (375-385), Online publication date: 2-Oct-2021. Pan T, Shen H, Yuan S, Lu G, Zhang Y, Wang H, Zhao Y, Sun X and Liu Q (2020) Combined Transplantation With Human Mesenchymal Stem Cells Improves Retinal Rescue Effect of Human Fetal RPE Cells in Retinal Degeneration Mouse Model, Investigative Opthalmology & Visual Science, 10.1167/iovs.61.8.9, 61:8, (9), Online publication date: 8-Jul-2020. Srinivasan S, Scharioth G, Riehl A, Tanev I, Rozsival P, Acker E, Nagy Z, Balta F and Nekolova J (2019) Implantation of Scharioth macula lens in patients with age-related macular degeneration: results of a prospective European multicentre clinical trial, BMJ Open Ophthalmology, 10.1136/bmjophth-2019-000322, 4:1, (e000322), Online publication date: 1-Jul-2019. 刘 桥 (2018) Advance in Risk Factors and Prevention of Dry Age-Related Macular Degeneration, Hans Journal of Ophthalmology, 10.12677/HJO.2018.71004, 07:01, (21-27), . Kara C, Özdal P, Beyazyıldız E, Özcan N, Teke M, Vural G and Öztürk F (2018) Increased levels of circulating CD34+ cells in neovascular age-related macular degeneration: relation with clinical and OCT features, European Journal of Ophthalmology, 10.5301/ejo.5001012, 28:1, (80-86), Online publication date: 1-Jan-2018. Hanus J, Zhao F and Wang S (2015) Current therapeutic developments in atrophic age-related macular degeneration, British Journal of Ophthalmology, 10.1136/bjophthalmol-2015-306972, 100:1, (122-127), Online publication date: 1-Jan-2016. Hanout M, Horan N and Do D (2015) Introduction to microperimetry and its use in analysis of geographic atrophy in age-related macular degeneration, Current Opinion in Ophthalmology, 10.1097/ICU.0000000000000153, 26:3, (149-156), Online publication date: 1-May-2015. García-Onrubia L, Valentín-Bravo F, Coco-Martin R, González-Sarmiento R, Pastor J, Usategui-Martín R and Pastor-Idoate S (2020) Matrix Metalloproteinases in Age-Related Macular Degeneration (AMD), International Journal of Molecular Sciences, 10.3390/ijms21165934, 21:16, (5934) Pedro C (2017) Single Intravitreal Injection of Etamsylate for the Treatment of Geographic Atrophy Associated with Submacular Hemorrhage, MOJ Clinical & Medical Case Reports, 10.15406/mojcr.2017.07.00186, 7:1 Nebbioso M, Lambiase A, Cerini A, Limoli P, La Cava M and Greco A (2019) Therapeutic Approaches with Intravitreal Injections in Geographic Atrophy Secondary to Age-Related Macular Degeneration: Current Drugs and Potential Molecules, International Journal of Molecular Sciences, 10.3390/ijms20071693, 20:7, (1693) Request Permissions InformationCopyright 2015, SLACK IncorporatedPDF downloadHershel R. Patel, MS, MD, can be reached at USF Eye Institute, 12901 Bruce B. Downs Blvd., MDC 21, Tampa, FL 33612; 516-318-5567; email: [email protected]com.David Eichenbaum, MD, can be reached at Retina Vitreous Associates of Florida, 12903 N 56th St, Tampa, FL 33617; 727-323-0077; email: [email protected]com.Disclosures: Dr. Patel has no relevant financial disclosures. Dr. Eichenbaum is an investigator, speaker and consultant to Genentech; an investigator for Ophthotech; a speaker and consultant for Allergan Retina; and an equity holder in Hemera Biosciences.